Cargando…
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants.
The blocking of angiogenesis provides a novel therapeutic target to inhibit tumour spreading. In this study, we investigated the effect of linomide on angiogenesis induced in vivo by highly angiogenic breast carcinoma cells. The rabbit cornea was used to assess neovascular growth in the absence of a...
Autores principales: | Ziche, M., Donnini, S., Morbidelli, L., Parenti, A., Gasparini, G., Ledda, F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150124/ https://www.ncbi.nlm.nih.gov/pubmed/9569049 |
Ejemplares similares
-
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing
por: Nannelli, Ginevra, et al.
Publicado: (2020) -
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents
por: Morbidelli, Lucia, et al.
Publicado: (2016) -
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance
por: Ciccone, Valerio, et al.
Publicado: (2020) -
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells
por: Ciccone, Valerio, et al.
Publicado: (2018) -
Correction to: Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells
por: Ciccone, Valerio, et al.
Publicado: (2019)